Ulrich Gerigk
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, RNA modifications and cancer, Lung Cancer Research Studies, Fibroblast Growth Factor Research
Most-Cited Works
- → K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways(2018)251 cited
- → MET Amplification Status in Therapy-Naïve Adeno- and Squamous Cell Carcinomas of the Lung(2014)189 cited
- → Clinical and Pathological Characteristics of KEAP1 - and NFE2L2 -Mutated Non–Small Cell Lung Carcinoma (NSCLC)(2018)163 cited
- → PIK3CA mutations in non-small cell lung cancer (NSCLC): Genetic heterogeneity, prognostic impact and incidence of prior malignancies(2014)139 cited
- → Definition of a fluorescence in-situ hybridization score identifies high- and low-level FGFR1 amplification types in squamous cell lung cancer(2012)129 cited
- → Clinicopathological Characteristics of RET Rearranged Lung Cancer in European Patients(2016)95 cited
- → Implementation of Amplicon Parallel Sequencing Leads to Improvement of Diagnosis and Therapy of Lung Cancer Patients(2015)94 cited
- → ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability(2015)93 cited
- → Rationale for Treatment of Metastatic Squamous Cell Carcinoma of the Lung Using Fibroblast Growth Factor Receptor Inhibitors(2012)48 cited
- → Co-occurrence of targetable mutations in Non-small cell lung cancer (NSCLC) patients harboring MAP2K1 mutations(2020)24 cited